Collectively, our results were consistent across several datasets, suggesting that ADCY5 and SLC2A1 could potentially serve as robust prognostic biomarkers for CC, and underscore a significant role played by the microenvironment in the progression of colon cancer. The gene discussed is SLC2A1; the disease is colonic neoplasm.